Towards Novel BIOmarkers to Diagnose SEPsis on the Emergency Room — Stella

Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

Towards Novel BIOmarkers to Diagnose SEPsis on the Emergency Room — Stella

Recruiting

Back to Sepsis trials

Trial locations(3 sites)

Netherlands

Flevoziekenhuis, Almere Stad, Flevoland

Amsterdam UMC, location VUMC, Amsterdam, North Holland

Amsterdam UMC, location AMC, Amsterdam, North Holland

Key details

Sponsor

Amsterdam University Medical Centers (UMC), Location Academic Medical Center (AMC)

Collaborators

Amsterdam UMC, location VUmc, Flevoziekenhuis

Enrollment target

~3,300 participants

Started

October 2022

Primary completion

October 2026

Age range

18 Years and older

Last updated October 2025

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Follow this trial

Get notified in plain English when this trial's status changes. No account required.

View full record on ClinicalTrials.gov